Canada · 
What does Genesys Capital invest in?
Genesys Capital invests most often at Series A and Series B (72% of the rounds on record), in sectors such as Biotechnology, Pharmaceuticals and Medical Technology.
Genesys Capital highlights
- 01
19 rounds on record
- 02
Mostly Series A and Series B: 72% of its rounds
- 03
Sole investor in 1 rounds, median $1.0M
- 04
2 exits from the portfolio
What they do
Genesys Capital is one of Canada's leading venture capital firms, investing in early-stage healthcare and biotechnology companiesFrom their own website
- Type
- VC firm
- Cheque size
- Not stated
- Stages
- Pre-seedSeedSeries A
- Sectors
- BiotechnologyPharmaceuticalsMedical Technology
- Based in
- Toronto, Canada
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first19 appearances
- 2021
1 round
- Jun
- 2019
1 round
- Dec
- 2018
1 round
- Jul
- 2017
1 round
- Feb
- 2014
1 round
- Oct
- 2013
1 round
- Dec
- 2012
2 rounds
- Dec
- Apr
- 2011
3 rounds
- Oct
- Jul
- May
- 2010
1 round
- Feb
- 2009
1 round
- Jul
- 2007
2 rounds
- Aug
- Mar
- 2006
2 rounds
- Aug
- Feb
- 2004
1 round
- Oct
- Undated
1 round
- -
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Affinium PharmaceuticalsBought by Debiopharm GroupUndisclosedFeb 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.